Literature DB >> 23232289

The employee absenteeism costs of inflammatory bowel disease: evidence from US National Survey Data.

Candace Gunnarsson1, Jie Chen, John A Rizzo, Joseph A Ladapo, Ahmad Naim, Jennifer H Lofland.   

Abstract

OBJECTIVE: To estimate indirect costs associated with inflammatory bowel disease (IBD).
METHODS: This was a retrospective study using 1996 to 2006 US Medical Expenditure Panel Survey data. Employed individuals were aged 18 to 64 years. A two-part model estimated the probability of time lost from work because of illness and the annual number of workdays missed.
RESULTS: A total of 71.5% (143/200) and 58.2% (52,257/89,846) of individuals with and without IBD, respectively, missed time from work because of illness (P = 0.0001). Among individuals who missed work, those with IBD missed more workdays annually than those without IBD ((Equation is included in full-text article.)= 13.38, 9.89, respectively; P = 0.044). Incremental per capita cost in annual lost workdays between those with and without IBD was $783. National indirect IBD-related costs were $249 million annually.
CONCLUSIONS: Individuals with IBD have higher probabilities of missing time from work and missing workdays than those without IBD.

Entities:  

Mesh:

Year:  2013        PMID: 23232289     DOI: 10.1097/JOM.0b013e31827cba48

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  6 in total

1.  Opportunities for Improvement in the Care of Patients Hospitalized for Inflammatory Bowel Disease-Related Colitis.

Authors:  Noel S Lee; Suresh Pola; Erik J Groessl; Jesus Rivera-Nieves; Samuel B Ho
Journal:  Dig Dis Sci       Date:  2016-02-10       Impact factor: 3.199

2.  Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.

Authors:  Aaron T Sin; Jennifer L Damman; David A Ziring; Elizabeth E Gleghorn; Manuel G Garcia-Careaga; Roberto R Gugig; Anna K Hunter; Jennifer C Burgis; Dorsey M Bass; K T Park
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

3.  The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Authors:  M Ellen Kuenzig; Lawrence Lee; Wael El-Matary; Adam V Weizman; Eric I Benchimol; Gilaad G Kaplan; Geoffrey C Nguyen; Charles N Bernstein; Alain Bitton; Kate Lee; Jane Cooke-Lauder; Sanjay K Murthy
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

Review 4.  A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease.

Authors:  Tiffany H Taft; Laurie Keefer
Journal:  Clin Exp Gastroenterol       Date:  2016-03-07

5.  The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel.

Authors:  Timna Naftali; Adi Eindor-Abarbanel; Nahum Ruhimovich; Ariella Bar-Gil Shitrit; Fabiana Sklerovsky-Benjaminov; Fred Konikoff; Shay Matalon; Haim Shirin; Yael Milgrom; Tomer Ziv-Baran; Efrat Broide
Journal:  Can J Gastroenterol Hepatol       Date:  2018-09-09

6.  Feeding Difficulties Associated with IBD during the Working Day: Qualitative Study, Alicante Spain.

Authors:  José R Matinez-Riera; José M Comeche-Guijarro; Ana Gutierrez-Hervas; Sofia García-Sanjuán; Pablo Caballero
Journal:  Int J Environ Res Public Health       Date:  2022-03-17       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.